COMMUNIQUÉS West-GlobeNewswire

FeraMAX est le supplemént de fer le plus recommandé au Canada depuis 11 années consécutives
01/04/2026
MISSISSAUGA, Ontario, 01 avr. 2026 (GLOBE NEWSWIRE) -- BioSyent inc. (« BioSyent », Bourse de croissance TSX : RX) est heureuse d’annoncer que FeraMAX MD a été désigné supplément de fer en vente libre le plus recommandé [...]
Avicanna Reports Full Year 2025 Audited Financial Statements
01/04/2026
Achieved positive adjusted EBITDA in Q4 2025 and near break-even $(0.29) million for the full year Advancements across business units, R&D, and clinical development to support scale and international growth TORONTO [...]
Calidi Biotherapeutics to Present New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026
01/04/2026
SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, will [...]
JenaValve Announces the Start of Commercialization of the Trilogy® Transcatheter Heart Valve System in the United States - the First and Only Transcatheter Device Approved for Symptomatic, Severe Aortic Regurgitation (ssAR)
01/04/2026
IRVINE, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy ® Transcatheter Heart Valve (THV) System, today announced the successful first cases and official [...]
AAVantgarde appoints Philip Lao as Senior Vice President of Business Development
01/04/2026
MILAN, April 01, 2026 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company pioneering therapies for inherited retinal diseases (IRDs) focused on large gene delivery via its two [...]
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference
01/04/2026
NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics , Inc. (NASDAQ: INKT ), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (allo-iNKT) cell therapies to restore [...]
OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI
01/04/2026
MINNEAPOLIS, April 01, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (the “OneMedNet,” the “Company,” “we,” “us” or “our”), a leading provider of regulatory decision-grade, AI-ready Real-World Data (RWD [...]
Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Virginia based Industrial Manufacturing Client
01/04/2026
VANCOUVER, British Columbia, April 01, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) developer of marijuana and alcohol breath testing [...]
Tilray Brands Delivers Record Q3 Fiscal 2026 Results; Net Revenue Increases to $207 Million with 11% Organic Growth and Gross Profit Expands to $55 Million, Increasing 6% Year-Over-Year
01/04/2026
International Cannabis Accelerates with 73% Net Revenue Growth and 100% Increase in Cannabis Flower Sales Volume Year-Over-Year Canadian Adult-Use and Medical Cannabis Net Revenue Combined Increased 8% Year-Over-Year; [...]
Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies
01/04/2026
SOUTH SAN FRANCISCO, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its [...]
Dyne Therapeutics Announces Participation at 2026 Academy of Managed Care Pharmacy (AMCP) Conference to Begin Shaping Access in US for Potential Neuromuscular Medicines
01/04/2026
- Poster on previously shared positive results from DELIVER clinical trial in Duchenne muscular dystrophy (DMD) contextualizes observed clinical measures of functional improvement for managed care experts - - Two [...]
Trevi Therapeutics to Participate in Upcoming Events
01/04/2026
NEW HAVEN, Conn., April 01, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the [...]
Soleo Health Selected as an Authorized Specialty Pharmacy of QIVIGY® For Primary Humoral Immunodeficiency (PI) Treatment
01/04/2026
FRISCO, Texas, April 01, 2026 (GLOBE NEWSWIRE) -- Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today it has been named a limited distribution specialty [...]
Rapport Therapeutics to Present New Phase 2 Treatment Follow-Up Data for RAP-219 in Focal Onset Seizures at the 2026 American Academy of Neurology Annual Meeting
01/04/2026
BOSTON and SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small [...]
Vireo Growth Inc. Announces Closing of Acquisition of Eaze Inc.
01/04/2026
Transaction expands Vireo’s operating footprint to 10 states with over 160 dispensaries and approximately 800,000 sq. ft. of cultivation and production Acquisition adds two new markets, California and Florida, and an [...]
NewcelX Announces Pricing of $1.35 Million Equity Financing at 30% Premium Pricing
01/04/2026
Financing reflects strong investor confidence and supports advancement of lead Type 1 Diabetes program ZURICH, Switzerland, April 01, 2026 (GLOBE NEWSWIRE) -- NewcelX Ltd. (Nasdaq: NCEL), a clinical-stage [...]
Johns Hopkins Health Plans Sits Down with Dundalk Seniors to Champion Community Connection
01/04/2026
Priority Partners and Advantage MD Join Seniors for an Afternoon of Food, Music and Community HANOVER, Md., April 01, 2026 (GLOBE NEWSWIRE) -- Johns Hopkins Health Plans joined Neighborhood Companions, Inc. at the [...]
Cost concerns now rival fear of cancer diagnosis, new survey finds
01/04/2026
ALEXANDRIA, Va., April 01, 2026 (GLOBE NEWSWIRE) -- “You have cancer.” The three words no one wants to hear. Routine cancer screenings can help prevent cancer or catch it early, when treatment is more likely to be [...]
Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset
01/04/2026
Provides guidance on interpretation of Topline dataset and confirms focus on drug-driven efficacy in non-melanoma skin cancer PHILADELPHIA, April 01, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus [...]

Pages